Liposomes as vehicles for targeted therapy of cancer. Part 2: Clinical development

被引：35

作者：

Harrington, KJ

Lewanski, CR

Stewart, JSW

机构：

[1] Mayo Clin, Program Mol Med, Rochester, MN 55902 USA

[2] Hammersmith Hosp, Imperial Canc Res Fund, Imperial Coll Sci Technol & Med, Oncol Unit, London, England

[3] Charing Cross Hosp, Dept Radiotherapy, London, England

来源：

CLINICAL ONCOLOGY | 2000年 / 12卷 / 01期

关键词：

D O I：

10.1053/clon.2000.9105

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：16 / 24

页数：9

共 81 条

[21] Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma [J].

Girard, PM ;

Bouchaud, O ;

Goetschel, A ;

Mukwaya, G ;

Eestermans, G ;

Ross, M ;

Rozenbaum, W ;

Saimot, AG .

AIDS, 1996, 10 (07) :753-757

[22] Efficacy and safety of stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma [J].

Goebel, FD ;

Goldstein, D ;

Goos, M ;

Jablonowski, H ;

Stewart, JS .

BRITISH JOURNAL OF CANCER, 1996, 73 (08) :989-994

[23]

GORDON KB, 1995, CANCER, V75, P2169, DOI 10.1002/1097-0142(19950415)75:8<2169::AID-CNCR2820750822>3.0.CO

[24]

2-H

[25] Targeting of stealth liposomes to erbB-2 (Her/2) receptor: In vitro and in vivo studies [J].

Goren, D ;

Horowitz, AT ;

Zalipsky, S ;

Woodle, MC ;

Yarden, Y ;

Gabizon, A .

BRITISH JOURNAL OF CANCER, 1996, 74 (11) :1749-1756

[26] Liposomes as vehicles for targeted therapy of cancer. Part 1: Preclinical development [J].

Harrington, KJ ;

Lewanski, CR ;

Stewart, JSW .

CLINICAL ONCOLOGY, 2000, 12 (01) :2-15

[27]

HARRINGTON KJ, 1998, P AN M AM SOC CLIN, V17, pA230

[28]

HARRINGTON KJ, 1996, AIDS MALIGNANCIES CU

[29]

HARRIS L, 1998, P AN M AM SOC CLIN, V17, pA124

[30] LIPOSOMAL-ENTRAPPED DOXORUBICIN - AN ACTIVE AGENT IN AIDS-RELATED KAPOSIS-SARCOMA [J].

HARRISON, M ;

TOMLINSON, D ;

STEWART, S .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (04) :914-920

← 1 2 3 4 5 6 7 8 9 →